title: In reply to Ozsahin and Azria.
authors.affiliation: Department of Radiation Oncology, Parc de Salut Mar, Universitat Pompeu Fabra, Barcelona, Spain.
authors.forename: Palmira
authors.initials: P
authors.lastname: Foro
authors.affiliation: Department of Radiation Oncology, Parc de Salut Mar, Universitat Pompeu Fabra, Barcelona, Spain.
authors.forename: Andrea
authors.initials: A
authors.lastname: Miralbell
authors.affiliation: Department of Radiation Oncology, Parc de Salut Mar, Universitat Pompeu Fabra, Barcelona, Spain.
authors.forename: Anna
authors.initials: A
authors.lastname: Ortiz
authors.affiliation: Department of Radiation Oncology, Parc de Salut Mar, Universitat Pompeu Fabra, Barcelona, Spain.
authors.forename: Manuel
authors.initials: M
authors.lastname: Algara
mesh_terms: D017209:Apoptosis; D015496:CD4-Positive T-Lymphocytes / Q000528:radiation effects*; D018414:CD8-Positive T-Lymphocytes / Q000528:radiation effects*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000532:radiotherapy*; D011878:Radiotherapy / Q000009:adverse effects*